Abbreviations

Abbreviations

  • 2‐AG
  • 2‐arachidonoylglycerol
  • 5‐HT
  • 5‐hydroxytryptamine (serotonin)
  • AD
  • antidepressant
  • AEA
  • arachidonoylethanolamide (anandamide)
  • AI
  • anti‐inflammatory
  • AMPA
  • α‐amino‐3‐hydroxyl‐5‐methyl‐4‐isoxazole‐propionate
  • Ca++
  • calcium ion
  • CB1/CB2
  • cannabinoid receptor 1 or 2
  • CBC
  • cannabichromene
  • CBCA
  • cannabichromenic acid
  • CBD
  • cannabidiol
  • CBDA
  • cannabidiolic acid
  • CBDV
  • cannabidivarin
  • CBG
  • cannabigerol
  • CBGA
  • cannabigerolic acid
  • CBGV
  • cannabigerivarin
  • CNS
  • central nervous system
  • COX
  • cyclo‐oxygenase
  • DAGL
  • diacylglycerol lipase
  • ECS
  • endocannabinoid system
  • EO
  • essential oil
  • FAAH
  • fatty acid amidohydrolase
  • FDA
  • US Food and Drug Administration
  • FEMA
  • Food and Extract Manufacturers Association
  • fMRI
  • functional magnetic resonance imaging
  • GABA
  • gamma aminobutyric acid
  • GPCR
  • G‐protein coupled receptor
  • GPR
  • G‐protein coupled receptor
  • HEK
  • human embryonic kidney
  • IC50
  • 50% inhibitory concentration
  • i.p
  • intraperitoneal
  • MAGL
  • monoacylglycerol lipase
  • MIC
  • minimum inhibitory concentration
  • MS
  • multiple sclerosis
  • NGF
  • nerve growth factor
  • NIDA
  • US National Institute on Drug Abuse
  • PG
  • prostaglandin
  • PTSD
  • post‐traumatic stress disorder
  • RCT
  • randomized clinical trial
  • SPECT
  • single photon emission computed tomography
  • SSADH
  • succinic semialdehyde dehydrogenase
  • Sx
  • symptoms
  • T1/2
  • half‐life
  • TCA
  • tricyclic antidepressant
  • THC
  • tetrahydrocannabinol
  • THCA
  • tetrahydrocannabinolic acid
  • THCV
  • tetrahydrocannabivarin
  • TNF‐α
  • tumour necrosis factor‐alpha, TRPV, transient receptor potential vanilloid receptor
  • Comments